Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Specific oncogene activation of the cell of origin in mucosal melanomaSwathy Babu, Jiajia Chen, Emily Robitschek, et al.
Nature Communications|July 22, 2025
Specific oncogene activation of the cell of origin in mucosal melanomaSwathy Babu, Jiajia Chen, Chloé S Baron, et al.
Cancer Discovery|May 7, 2020
Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Cancer Immunology Research|September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal CancerBrandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
JCO Precision Oncology|July 7, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor BenefitRomualdo Barroso-Sousa, Juliet Forman, Katharine Collier, et al.
Cell|September 17, 2021
Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumorsMegan L Burger, Amanda M Cruz, Grace E Crossland, et al.
Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 MonotherapyXue Bai, Jiani Hu, Allison Betof Warner, et al.
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Pageof 5